FirmaIQ
Org.nr 979 455 518 2019 → 2020 Year-over-year analysis

ACD PHARMACEUTICALS AS: årsregnskap 2020 vs 2019

Shrank 15% on revenue

approved 2021-05-31; registry 2021-08-14; journal 2021 613500

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2020 with 2019 for ACD PHARMACEUTICALS AS. Revenue 20.03m NOK → 17.08m NOK (-14.7%). Net result +10.44m NOK → +9.12m NOK. Equity 2.77m NOK → 11.89m NOK.

On the constructive side: operating result improved; equity strengthened; cash rose. Pressures included: revenue fell; net result weakened.

Mixed year — gains and pressures both show up.

At a glance

Scorecard

Revenue
20.03m NOK 17.08m NOK
-14.7%
Operating result
+10.20m NOK +11.32m NOK
+11.0%
Net result
+10.44m NOK +9.12m NOK
-12.7%
Equity
2.77m NOK 11.89m NOK
+328.7%
Cash
141.0k NOK 10.42m NOK
+7291.6%
Total assets
16.20m NOK 25.54m NOK
+57.6%

What improved

  • ↑

    Operating result improved

    Operating result +10.20m NOK → +11.32m NOK (op. margin 50.9% → 66.3%). Calculated

  • ↑

    Equity strengthened

    Book equity 2.77m NOK → 11.89m NOK (equity ratio 17.1% → 46.6%). Calculated

  • ↑

    Cash rose

    Bank deposits 141.0k NOK → 10.42m NOK (+7291.6% YoY). Calculated

What deteriorated

  • ↓

    Revenue fell

    Operating income / revenue moved from 20.03m NOK to 17.08m NOK (-14.7% YoY). Calculated

  • ↓

    Net result weakened

    Net result +10.44m NOK → +9.12m NOK (net margin 52.1% → 53.4%). Calculated